2.27
BioMarin Pharmaceutical Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
billions USD
FY21:
FY22:
2.75
FY23:
2.96
FY24:
3.23
FY25:
3.95
(positive)
Change from FY21 to FY25
billions USD
FY21:
3.73
FY22:
3.62
FY23:
3.89
FY24:
3.76
FY25:
3.64
Total assets
Change from FY21 to FY25
billions USD
FY21:
6.00
FY22:
6.38
FY23:
6.84
FY24:
6.99
FY25:
7.59
Liabilities & Equity
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.55
FY22:
0.59
FY23:
1.18
FY24:
0.61
FY25:
0.76
(negative)
Change from FY21 to FY25
billions USD
FY21:
1.19
FY22:
1.18
FY23:
0.71
FY24:
0.72
FY25:
0.75
(positive)
Change from FY21 to FY25
billions USD
FY21:
4.27
FY22:
4.60
FY23:
4.95
FY24:
5.66
FY25:
6.09
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
6.00
FY22:
6.38
FY23:
6.84
FY24:
6.99
FY25:
7.59
All amounts in billions USD